H L Verrill

516 total citations
16 papers, 408 citations indexed

About

H L Verrill is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, H L Verrill has authored 16 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in H L Verrill's work include Muscle Physiology and Disorders (4 papers), Genetic Neurodegenerative Diseases (4 papers) and Glycosylation and Glycoproteins Research (3 papers). H L Verrill is often cited by papers focused on Muscle Physiology and Disorders (4 papers), Genetic Neurodegenerative Diseases (4 papers) and Glycosylation and Glycoproteins Research (3 papers). H L Verrill collaborates with scholars based in United States and United Kingdom. H L Verrill's co-authors include H D Gruemer, E.S. Newlands, Stephen A. Butler, Shohreh Shahabi, Laurence A. Cole, Hugh Mitchell, Hilary Koprowski, Harold R. Behrman, Walter E. Nance and Barbara Goldsmith and has published in prestigious journals such as New England Journal of Medicine, Neurology and Anesthesiology.

In The Last Decade

H L Verrill

15 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H L Verrill United States	12	201	74	72	56	55	16	408
Cheryl Y. Tiarks United States	12	141 0.7×	21 0.3×	39 0.5×	75 1.3×	17 0.3×	21	505
B. Daicker Switzerland	13	190 0.9×	212 2.9×	56 0.8×	19 0.3×	23 0.4×	89	677
Y Kawashima Japan	9	168 0.8×	72 1.0×	63 0.9×	146 2.6×	65 1.2×	43	489
Larry Lam United States	12	178 0.9×	27 0.4×	29 0.4×	34 0.6×	38 0.7×	17	398
R. Hofmann Germany	13	47 0.2×	40 0.5×	77 1.1×	59 1.1×	27 0.5×	59	450
Elizabeth McElnea Ireland	12	147 0.7×	117 1.6×	48 0.7×	15 0.3×	12 0.2×	41	485
Anne Cook United Kingdom	12	102 0.5×	191 2.6×	25 0.3×	26 0.5×	61 1.1×	19	464
Daniel Feinberg United States	12	169 0.8×	30 0.4×	16 0.2×	65 1.2×	10 0.2×	25	440
Maria Cucinotta Italy	14	140 0.7×	30 0.4×	21 0.3×	84 1.5×	21 0.4×	19	498
Hadas Mechoulam Israel	11	72 0.4×	158 2.1×	80 1.1×	36 0.6×	21 0.4×	26	393

Countries citing papers authored by H L Verrill

Since Specialization

Citations

This map shows the geographic impact of H L Verrill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H L Verrill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H L Verrill more than expected).

Fields of papers citing papers by H L Verrill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H L Verrill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H L Verrill. The network helps show where H L Verrill may publish in the future.

Co-authorship network of co-authors of H L Verrill

This figure shows the co-authorship network connecting the top 25 collaborators of H L Verrill. A scholar is included among the top collaborators of H L Verrill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H L Verrill. H L Verrill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Cole, Laurence A., Shohreh Shahabi, Stephen A. Butler, et al.. (2001). Utility of Commonly Used Commercial Human Chorionic Gonadotropin Immunoassays in the Diagnosis and Management of Trophoblastic Diseases. Clinical Chemistry. 47(2). 308–315. 98 indexed citations

Abuzeid, Mostafa I., et al.. (1999). Remifentanil and Fentanyl Concentrations in Follicular Fluid During Transvaginal Oocyte Retrieval. Anesthesiology. 90(Supplement). 16A–16A. 7 indexed citations

Stone, Jennifer, et al.. (1998). Hemodynamic and hormonal changes during pneumoperitoneum and trendelenburg positioning for operative gynecologic laparoscopy surgery. Primary Care Update for OB/GYNS. 5(4). 155–155. 16 indexed citations

Verrill, H L, et al.. (1989). Comparison of Serum CA 19–9 and CEA Levels in a Population at High Risk for Colorectal Cancer. Hybridoma. 8(5). 569–575. 17 indexed citations

Verrill, H L, et al.. (1987). Distribution of cyclosporine in blood of a renal-transplant recipient with type V hyperlipoproteinemia.. Clinical Chemistry. 33(3). 423–428. 21 indexed citations

Verrill, H L, et al.. (1986). Clinical trial of Wistar Institute 17-1A monoclonal antibody in patients with advanced gastrointestinal adenocarcinoma: a preliminary report.. PubMed. 5 Suppl 1. S175–83. 19 indexed citations

Herlyn, Meenhard, Jianwei Shen, Henry F. Sears, et al.. (1984). Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants.. PubMed. 55(1). 23–35. 23 indexed citations

Verrill, H L, et al.. (1984). Evaluation of monoclonal antibody to 19-9 antigen as a potential screening technique for colorectal cancer in a high-risk population.. PubMed. 156. 107–14.

Herlyn, Meenhard, Henry F. Sears, H L Verrill, & Hilary Koprowski. (1984). Increased sensitivity in detecting tumor-associated antigens in sera of patients with colorectal carcinoma. Journal of Immunological Methods. 75(1). 15–21. 18 indexed citations

10.

Herlyn, Meenhard, M Błaszczyk, Henry F. Sears, et al.. (1983). Detection of Carcinoembryonic Antigen and Related Antigens in Sera of Patients with Gastrointestinal Tumors Using Monoclonal Antibodies in Double-Determinant Radioimmunoassays. Hybridoma. 2(3). 329–339. 32 indexed citations

11.

Gruemer, H D, et al.. (1980). The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait.. Clinical Chemistry. 26(6). 754–759. 8 indexed citations

12.

Gruemer, H D, et al.. (1978). Systemic Membrane Defect in the Proximal Muscular Dystrophies. New England Journal of Medicine. 299(16). 841–846. 93 indexed citations

13.

Verrill, H L, et al.. (1977). Mechanisms of cellular enzyme release. I. Alteration in membrane fluidity and permeability.. Clinical Chemistry. 23(12). 2219–2225. 16 indexed citations

14.

Verrill, H L, et al.. (1977). Diminished cap formation in lymphocytes from patients and carriers of Duchenne muscular dystrophy.. Clinical Chemistry. 23(12). 2341–2343. 26 indexed citations

15.

Verrill, H L, H D Gruemer, & Nobuhisa Baba. (1977). Mechanisms of cellular enzyme release. II. Inhibition of sarcolemmal enzymes by myopathy-inducing agents.. Clinical Chemistry. 23(12). 2226–2230. 3 indexed citations

16.

Mendell, Jerry R., et al.. (1976). Imipramine‐serotonin induced myopathy. Neurology. 26(10). 968–968. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact